Stonehage Fleming (UK)’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-134
Closed -$49K 308
2013
Q4
$49K Buy
+134
New +$49K 0.02% 228